TABLE 4.
HIV-1C protein | aa
|
Amino acid sequencea | Frequency of CTL responses (% of samples) | Normalized cumulative CTL responsesb | Amino acid diversityc
|
|||
---|---|---|---|---|---|---|---|---|
Start | End | % | P value | Mean difference, % (95% CI) | ||||
Gag | 161 | 180 | EKAFSPEVIPMFTALSEGAT | 10.2 | 47.3 | 3.2 | <0.0001 | 6.2 (4.8, 7.6) |
171 | 190 | MFTALSEGATPQDLNTMLNT | 32.2 | 190.5 | 2.5 | <0.0001 | 6.9 (5.5, 8.4) | |
291 | 310 | EPFRDYVDRFFKTLRAEQAT | 18.6 | 80.2 | 3.2 | 0.0062 | 1.9 (0.5, 3.2) | |
301 | 320 | FKTLRAEQATQDVKNWMTDT | 17.0 | 87.7 | 5.5 | <0.0001 | 4.0 (2.1, 5.9) | |
331 | 350 | KTILRALGPGATLEEMMTAC | 15.3 | 43.7 | 7.2 | 0.0043 | 2.2 (0.7, 3.7) | |
Pol | 271 | 290 | FSVPLDEDFRKYTAFTIPSI | 12.7 | 48.8 | 9.3 | 0.0064 | −2.8 (−4.9, −0.8) |
421 | 440 | WASQIYPGIKVRQLCKLLRG | 10.9 | 44.8 | 9.9 | 0.12 | −3.5 (−8.0, 1.0) | |
521 | 540 | KQLTEAVOKIAMESIVIWGK | 10.9 | 27.3 | 11.2 | <0.0001 | −4.8 (−6.8, −2.9) | |
894 | 911 | AVFIHNFKRKGGIGGYSA | 14.1 | 41.4 | 3.0 | <0.0001 | 3.4 (2.5, 4.4) | |
925 | 942 | TKELQKQIIKIQNFRVYY | 15.6 | 36.7 | 9.8 | 0.00025 | −3.4 (−5.3, −1.6) | |
Vif | 61 | 80 | EARLVIKTYWGLOTGERDWH | 12.7 | 32.8 | 18.4 | <0.0001 | −6.8 (−9.5, −4.0) |
71 | 90 | GLQTGERDWHLGHGVSIEWR | 16.4 | 41.1 | 9.4 | 0.016 | 2.2 (0.4, 3.9) | |
Vpr | 31 | 50 | VRHFPRPWLHSLGQYIYETY | 21.4 | 52.6 | 19.4 | <0.0001 | −7.5 (−9.9, −5.0) |
Tat | 16 | 30 | SQPKTACNKCYCKRC | 10.7 | 25.0 | 31.8 | <0.0001 | −13.5 (−16.5, −10.4) |
36 | 50 | VCFQTKGLGISYGRK | 30.4 | 96.0 | 11.9 | <0.0001 | 5.9 (3.9, 7.9) | |
Env | 299 | 319 | PNNNTRKSIRIGPGQTFYA | 11.3 | 28.1 | 10.7 | <0.0001 | 9.4 (7.6, 11.1) |
552 | 571 | QSNLLRAIEAQQHMLQLTVW | 10.7 | 25.2 | 4.9 | <0.0001 | 15.1 (14.0, 16.2) | |
702 | 721 | LSIVNRVRQGYSPLSFQTLT | 10.7 | 29.3 | 8.7 | <0.0001 | 11.3 (9.3, 13.4) | |
742 | 761 | RDRSIRLVSGFLALAWDDLR | 19.6 | 42.2 | 17.4 | 0.028 | 2.6 (0.3, 5.0) | |
Nef | 1 | 16 | MGGKWSKSSIVGWPAV | 12.7 | 27.9 | 25.8 | 0.0059 | −7.2 (−12.3, −2.1) |
67 | 81 | GFPVRPQVPLRPMTY | 12.7 | 45.1 | 9.2 | <0.0001 | 9.4 (5.5, 13.3) | |
72 | 86 | PQVPLRPMTYKGAFD | 16.4 | 43.8 | 16.1 | 0.20 | 2.5 (−1.3, 6.2) | |
77 | 91 | RPMTYKGAFDLSFFL | 12.7 | 35.2 | 20.1 | 0.35 | −0.5 (−4.7, 1.6) | |
82 | 96 | KGAFDLSFFLKEKGG | 20.0 | 60.4 | 16.3 | 0.064 | 2.3 (−0.1, 4.7) | |
97 | 111 | LEGLIYSKKRQEILD | 12.7 | 40.7 | 15.2 | 0.0095 | 3.4 (0.8, 6.0) | |
112 | 126 | LWVYHTQGYFPDWQN | 16.4 | 38.4 | 11.1 | <0.0001 | 7.5 (5.5, 9.6) | |
122 | 136 | PDWQNYTPGPGVRYP | 18.2 | 50.6 | 9.0 | <0.0001 | 9.7 (7.4, 11.9) | |
127 | 141 | YTPGPGVRYPLTFGW | 14.5 | 56.9 | 8.5 | <0.0001 | 10.1 (8.0, 12.2) |
The top eight immunodominant regions are in boldface.
Cumulative CTL responses were normalized by the number of samples screened with a particular set of synthetic peptides.
The amino acid diversity for a particular immunodominant region was compared with the amino acid diversity of the entire corresponding viral protein (P value and mean difference).